Evaluation of vancomycin use in university-affiliated hospitals in Southern Khorasan Province (East Iran) based on HICPAC guidelines

References

• HolpuchAUN Meeting Tackles the’ Fundamental Threat’ of Antibiotic-Resistant SuperbugsUKThe Guardian2016
   Google Scholar
• SalehifarENasehiMEslamiGSahraeiSAlizadeh NavaeiRDetermination of antibiotics consumption in Buali-Sina Pediatric Hospital, Sari 2010–2011Iran J Pharm Res201413399525276201
   PubMed Web of Science ®Google Scholar
• LaxminarayanRDuseAWattalCAntibiotic resistance-the need for global solutionsLancet Infect Dis201313121057109824252483
   PubMed Web of Science ®Google Scholar
• NaderiAKasra-KermanshahiRGharaviSImani FooladiAAAbdollahpourAMSaffarianPStudy of antagonistic effects of Lactobacillus strains as probiotics on multi drug resistant (MDR) bacteria isolated from urinary tract infections (UTIs)Iran J Basic Med Sci201417320120824847423
   PubMed Web of Science ®Google Scholar
• DenoonDDrug-resistant staph may get nastier: experts call for increased efforts to halt MRSAWebMD Medical News2008
   Google Scholar
• MoranGJKrishnadasanAGorwitzRJMethicillin-resistant S. aureus infections among patients in the emergency departmentN Engl J Med2006355766667416914702
   PubMed Web of Science ®Google Scholar
• FrazeeBWLynnJCharleboisEDLambertLLoweryDPerdreau-RemingtonFHigh prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infectionsAnn Emerg Med200545331132015726056
   PubMed Web of Science ®Google Scholar
• ChambersHFCommunity-associated MRSA—resistance and virulence convergeMass Medical Soc20053521414851487
   Google Scholar
• WilsonPAndrewsJACharlesworthRLinezolid resistance in clinical isolates of Staphylococcus aureusJ Antimicrob Chemother200351118618812493812
   PubMed Web of Science ®Google Scholar
• HagrasMMohammadHMandourMSInvestigating the antibacterial activity of biphenylthiazoles against methicillin- and vancomycin-resistant Staphylococcus aureus (MRSA and VRSA)J Med Chem20176094074408528436655
   PubMed Web of Science ®Google Scholar
• YeZKLiCZhaiSDGuidelines for therapeutic drug monitoring of vancomycin: a systematic reviewPLoS One201496e9904424932495
   PubMed Web of Science ®Google Scholar
• JavorskaLKrcmovaLKSolichovaDSolichPKaskaMModern methods for vancomycin determination in biological fluids by methods based on high-performance liquid chromatography–a reviewJ Sep Sci201639162026351070
   PubMed Web of Science ®Google Scholar
• AbbasQUl HaqAKumarRAliSAHussainKShakoorSEvaluation of antibiotic use in pediatric intensive care unit of a developing countryIndian J Crit Care Med201620529127275078
   PubMedGoogle Scholar
• ErbayAÇolpanABodurHÇevikMASamoreMHErgönülOEvaluation of antibiotic use in a hospital with an antibiotic restriction policyInt J Antimicrob Agents200321430831212672575
   PubMed Web of Science ®Google Scholar
• ArdaBSipahiORYamazhanTShort-term effect of antibiotic control policy on the usage patterns and cost of antimicrobials, mortality, nosocomial infection rates and antibacterial resistanceJ Infect2007551414817512598
   PubMed Web of Science ®Google Scholar
• Garnacho-MonteroJGutiérrez-PizarrayaAEscoresca-OrtegaADe-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shockIntensive Care Med2014401324024026297
   PubMed Web of Science ®Google Scholar
• DaveyPBrownECharaniEInterventions to improve antibiotic prescribing practices for hospital inpatientsCochrane Database Syst Rev201344
   Web of Science ®Google Scholar
• SpauldingTJRaghuTSImpact of CPOE usage on medication management process costs and quality outcomesInquiry-J Health Car2013503229247
   Google Scholar
• DingHYangYChenYWangYFanSShenXAntimicrobial usage in paediatric intensive care units in ChinaActa Paediatr200897110010418076718
   PubMed Web of Science ®Google Scholar
• BlinovaELauEBitnunAPoint prevalence survey of antimicrobial utilization in the cardiac and pediatric critical care unitPediatr Crit Care Med2013146e280e28823823209
   PubMed Web of Science ®Google Scholar
• StockerMFerraoEBanyaWCheongJMacraeDFurckAAntibiotic surveillance on a paediatric intensive care unit: easy attainable strategy at low costs and resourcesBMC Pediatr201212119623259701
   PubMed Web of Science ®Google Scholar
• FloretNThouverezMThalamyBEstavoyerJMTalonDEvaluation of vancomycin use in a large university-affiliated hospital in eastern France in 1999Pharm World Sci2001233939711468882
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC)Nosocomial enterococci resistant to vancomycin–United States, 1989–1993MMWR Morb Mortal Wkly Rep199342305978336690
   PubMedGoogle Scholar
• SolomkinJSMazuskiJBlanchardJCIntroduction to the Centers for Disease Control and Prevention and the Healthcare Infection Control Practices Advisory Committee guideline for the prevention of surgical site infectionsSurg Infect2017184385393
   PubMed Web of Science ®Google Scholar
• WaleMKibseyPYoungLDobbynBArcherJNew approaches to infection prevention and control: implementing a risk-based model regionallyInt J Qual Health Care201628340541127194074
   PubMed Web of Science ®Google Scholar
• PaiMPNeelyMRodvoldKALodiseTPInnovative approaches to optimizing the delivery of vancomycin in individual patientsAdv Drug Deliv Rev201477505724910345
   PubMed Web of Science ®Google Scholar
• SpitzerEDTortoraGTVancomycin-resistant gram-positive cocciLab Med1990217411413
   Web of Science ®Google Scholar
• BenvenutoMBenzigerDPYankelevSViglianiGPharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteersAntimicrob Agents Chemother200650103245324917005801
   PubMed Web of Science ®Google Scholar
• FigueroaDAManginiEAmodio-GrotonMSafety of high-dose intravenous daptomycin treatment: three-year cumulative experience in a clinical programClin Infect Dis200949217718019500039
   PubMed Web of Science ®Google Scholar
• FletcherCGieseRRodmanJPharmacist interventions to improve prescribing of vancomycin and tobramycinAm J Health Syst Pharm198643921982201
   Web of Science ®Google Scholar
• AnagnostouTGoundanPHoynackEEvaluation of Vancomycin usage after Implementation of an Antibiotic Stewardship Program: Experience from a Community-Based Teaching HospitalOpen Forum Infectious DiseasesOxford University Press2015
   Google Scholar
• KimNHKooHLChoePGInappropriate continued empirical vancomycin use in a hospital with a high prevalence of methicillin-resistant Staphylococcus aureusAntimicrob Agents Chemother201559281181725403664
   PubMed Web of Science ®Google Scholar
• AlfandariSLeventTDescampsDEvaluation of glycopeptide use in nine French hospitalsMed Mal Infect201040423223719959309
   PubMed Web of Science ®Google Scholar
• RybakMLomaestroBRotschaferJCTherapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases PharmacistsAm J Health Syst Pharm2009661829819106348
   PubMedGoogle Scholar
• IstúrizRECarbonCAntibiotic use in developing countriesInfect Control Hosp Epidemiol200021639439710879571
   PubMed Web of Science ®Google Scholar
• PowellSLLiebeltEAppropriate use of vancomycin in a pediatric emergency department through the use of a standardized electronic guidelineJ Pediatr Nurs201530349449725618611
   PubMed Web of Science ®Google Scholar
• CetinkayaYFalkPMayhallCGVancomycin-resistant enterococciClin Microbiol Rev200013468670711023964
   PubMed Web of Science ®Google Scholar
• AskarianMAssadianOSafaeeGGolkarANamaziSMovahedMRVancomycin use in a large teaching hospital in Shiraz, Islamic Republic of Iran, 2003East Mediterr Health J20071351195120118290414
   PubMedGoogle Scholar
• DibJGAl-TawfiqJAAl AbdulmohsinSMohammedKJendenPDImprovement in vancomycin utilization in adults in a Saudi Arabian medical center using the hospital infection control practices advisory committee guidelines and simple educational activityJ Infect Public Health20092314114620701874
   PubMedGoogle Scholar
• JuniorMSCorreaLMarraARCamargoLFPereiraCAAnalysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort studyBMC Infect Dis2007718817678541
   PubMed Web of Science ®Google Scholar
• VazinAMahi BirjandMDarakeMEvaluation of vancomycin therapy in the adult ICUs of a teaching hospital in southern IranDrug Healthc Patient Saf201810212629670404
   PubMed Web of Science ®Google Scholar
• MisanGMMartinEDSmithERSomogyiAABartholomeuszRCBochnerFDrug utilization review in a teaching hospital: experience with vancomycinEur J Clin Pharmacol19903954574612076737
   PubMed Web of Science ®Google Scholar
• KernWVde WithKGonnermannCUpdate on glycopeptide use in German university hospitalsInfection200432315716215188076
   PubMed Web of Science ®Google Scholar
• FridkinSKVancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to knowClin Infect Dis200132110811511118389
   PubMed Web of Science ®Google Scholar
• FahimiFSoleymaniFTavakoli-ArdakaniMVancomycin Utilization Evaluation in a teaching hospital: A case-series study in IranJ Pharm Care2013514
   Google Scholar